Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 정혜경 | * |
dc.contributor.author | 태정현 | * |
dc.date.accessioned | 2022-02-22T16:30:57Z | - |
dc.date.available | 2022-02-22T16:30:57Z | - |
dc.date.issued | 2022 | * |
dc.identifier.issn | 2093-0879 | * |
dc.identifier.other | OAK-30863 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/260562 | - |
dc.description.abstract | Background/Aims Patient-reported outcomes (PROs) are essential for clinical decision making, conduction of clinical research, and drug application acquisition in functional gastrointestinal disorders. The aim of this study is to develop a PRO instrument and to determine the respondents’ perception of the efficacy of therapeutic agents for functional dyspepsia (FD). Methods A self-evaluation questionnaire for dyspepsia (SEQ-DYSPEPSIA) was developed and validated through a structured process. The 2-week reproducibility was evaluated, and the construct validity was assessed by correlating the scores of SEQ-DYSPEPSIA (including typical and major FD symptom subscales). Finally, the response to medication was assessed by comparing the changes after 4 weeks of treatment. Results A total of 193 Korean patients (age 48.5 ± 13.6 years, 69.4% women) completed the questionnaire. SEQ-DYSPEPSIA with 11 items had a good internal consistency (alpha = 0.770-0.905) and an acceptable test-retest reliability (intraclass correlation coefficient = 0.733-0.859). The self-evaluation questionnaire (SEQ)-major FD score highly correlated with the postprandial fullness/early satiety domain of the Patient Assessment of Gastrointestinal Symptom Severity Index (correlation coefficient r = 0.741, P < 0.001), Nepean Dyspepsia Index-Korean version (NDI-K) (r = 0.839, P < 0.001), and NDI-K quality of life (r = −0.275 to −0.344, P < 0.001). After medical treatment, decrease in the SEQ-typical FD and SEQ-major FD was significantly greater in the responder group than in non-responder group (P = 0.019 and P = 0.009, respectively). Conclusion This study suggests that the Korean version of SEQ-DYSPEPSIA has good reliability and validity, and can be a useful PRO measurement tool in patients with FD. © 2022 The Korean Society of Neurogastroenterology and Motility | * |
dc.language | English | * |
dc.publisher | Korean Society of Neurogastroenterology and Motility | * |
dc.subject | Dyspepsia | * |
dc.subject | Patient outcome assessment | * |
dc.subject | Surveys and questionnaires | * |
dc.subject | Validation study | * |
dc.title | Development and Validity Assessment of a Self-evaluation Questionnaire for Functional Dyspepsia: A Multicenter Prospective Study in Korea | * |
dc.type | Article | * |
dc.relation.issue | 1 | * |
dc.relation.volume | 28 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.index | KCI | * |
dc.relation.startpage | 111 | * |
dc.relation.lastpage | 120 | * |
dc.relation.journaltitle | Journal of Neurogastroenterology and Motility | * |
dc.identifier.doi | 10.5056/JNM20250 | * |
dc.identifier.wosid | WOS:000741162300014 | * |
dc.identifier.scopusid | 2-s2.0-85123024523 | * |
dc.author.google | Jung K. | * |
dc.author.google | Jung H.-K. | * |
dc.author.google | Kwon J.G. | * |
dc.author.google | Tae C.H. | * |
dc.author.google | Bang K.B. | * |
dc.author.google | Park J.K. | * |
dc.author.google | Lee J.Y. | * |
dc.author.google | Shin C.M. | * |
dc.author.google | Oh J.H. | * |
dc.author.google | Song K.H. | * |
dc.author.google | Lee O.Y. | * |
dc.author.google | Choi M.-G. | * |
dc.contributor.scopusid | 정혜경(7403029723) | * |
dc.contributor.scopusid | 태정현(35211966400) | * |
dc.date.modifydate | 20240308140308 | * |